Skip to main navigation Skip to search Skip to main content

Southwest Oncology Group Trial S9912: Intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer

  • Harriet O. Smith
  • , James Moon
  • , Sharon P. Wilczynski
  • , Amy D. Tiersten
  • , Edward V. Hannigan
  • , William R. Robinson
  • , Saul E. Rivkin
  • , Garnet L. Anderson
  • , P. Y. Liu
  • , Maurie Markman

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Southwest Oncology Group Trial S9912: Intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science